Abstract
Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Allergy and Clinical Immunology |
| Vol/bind | 129 |
| Udgave nummer | 2 |
| Sider (fra-til) | 413-9 |
| Antal sider | 7 |
| ISSN | 0091-6749 |
| DOI | |
| Status | Udgivet - 2012 |